On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayAug 12, 2022 2:53 pm

QualityStocksNewsBreaks – Silo Pharma Inc.’s (SILO) Ketamine Study Generates ‘Extremely Promising’ Data

Silo Pharma (OTCQB: SILO), a development-stage biopharmaceutical company, recently completed an animal study of its ketamine formulation, showing nerve pain reduction when administered using a patented delivery system developed in partnership with Zylo Therapeutics. “Results from the small animal study produced positive endpoint results, demonstrating that Silo’s topical ketamine formulation reduced mechanical allodynia and hyperalgesia at both the pre- and post-dosing time points. Mechanical hyperalgesia was additionally reduced on day seven at the pre-dose time point. ‘These positive results of our study show that Silo is able to successfully formulate and deliver ketamine topically at reduced dosage to achieve its…

Continue Reading

FridayAug 12, 2022 1:29 pm

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Looking to Solve Medical Challenge in Immune Responses

Aditxt (NASDAQ: ADTX) has sought to address a medical conundrum: approximately 50% of all transplanted organs are rejected by the host’s body within 10-12 years despite a wide array of medical innovations in recent years. This highlights the critical need for a practical, cost-effective solution to harmful immune responses. Aditxt is looking to solve this medical problem “through the creation of immune reprogramming technologies, which are being developed to retrain the immune system to induce tolerance to transplanted organs, self-tissues (autoimmune diseases) and allergens,” a recent article reads. “While still at a pre-clinical stage, ADi(TM) (Apoptotic DNA Immunotherapy), the company’s…

Continue Reading

FridayAug 12, 2022 1:08 pm

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) 360-Degree Offering Promoting Artists’ Independence, Revenue Generation

Friendable (OTC: FDBL), a mobile technology and marketing company, announced its acquisition of Artist Republik and FeaturedX in January 2022, bringing together a 360-degree suite of services for artists. The acquisition completed the company’s flagship offering, Fan Pass Live. “Artists can now sign up for the Fan Pass Live artist platform and benefit from music production, distribution and marketing services without the control of music labels pulling the strings or eating up revenue… The 360-degree suite of Fan Pass Live, Artist Republik and FeaturedX promotes being an independent label in an artist’s pocket, meaning there are no gatekeepers, no middleman,…

Continue Reading

FridayAug 12, 2022 12:40 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Positioning Berubicin Clinical Development Program for Success

CNS Pharmaceuticals (NASDAQ: CNSP) is currently recruiting patients for a phase II study evaluating the efficacy and safety of Berubicin, its lead drug candidate for treating glioblastoma multiforme (“GBM”), the most aggressive, deadly and treatment-resistant type of cancer that forms in the brain. Recently, the company announced that the FDA had approved an amendment to the study’s protocol, boosting its Berubicin clinical development program. “The amendment expands eligibility for its potentially pivotal study to patients who have received additional treatments as part of the first-line therapy,” explains a recent article. “The key objectives of the amendment, according to CNS Pharmaceuticals…

Continue Reading

ThursdayAug 11, 2022 2:16 pm

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Micro-Tracker, Asset-Tracking News Featured in Emerging Markets Report

SPYR (OTCQB: SPYR), a diversified technology company developing products and leveraging the Internet of Things (“Iot”) for consumer use and large-scale applications and industries, and its subsidiary GeoTraq, were mentioned in a recent Emerging Markets Report. The report noted that SPYR focus is developing, marketing and positioning the GeoTraq small transmitter tracking devices, including the company’s newest offering, the Micro-Tracker(R), as the leading edge of IoT asset tracking technology. The announcement noted that these proprietary tracking devices can be used to monitor and track everything from Porta-Potties at major music festivals to locating construction assets at a job site; the devices are…

Continue Reading

ThursdayAug 11, 2022 12:33 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Approval to Manufacture Hemp-Derived CBD Products in South Easton Facility

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide biopharmaceuticals and other industries. The company today announced approval for its South Easton, Massachusetts, facility to manufacture custom, compliant, hemp-derived CBD nanoemulsions under the processing/manufacturing license of its commercial partner, Canopy CBD Farms (“CCF”). CFF is a Massachusetts-licensed hemp processing and manufacturing company. “I am delighted to partner with PBI by extending my CBD processing and manufacturing license to PBI’s South Easton location,” said John Westlake, founder and president of CCF. “I firmly believe…

Continue Reading

ThursdayAug 11, 2022 12:14 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Discusses Biotech Industry Valuation Metrics

Lexaria Bioscience (NASDAQ: LEXX, LEXXW) is a global innovator in drug delivery platforms. The company today issued information to its stakeholders as an aid to conveniently research and understand various non-affiliated third-party sources and their methodologies for valuing biotech and pharmaceutical companies. “Biotech companies with little to no revenue can still be worth billions,” Raphael Rottgen, CFA, FRM, was quoted in the press release. “While valuations can be extremely low or extremely high, there is often underlying logic in identifying risks and arriving at those valuations. Developing new drugs can have significant costs of over $1 billion and can take…

Continue Reading

ThursdayAug 11, 2022 12:02 pm

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR) Announces Live Dealer Studio GLI Certification for Ontario and Isle of Man

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR), a propriety SaaS technology company delivering “state-of-the-art” mobile live dealer technology and eTable games to online gaming operators globally, announced that it is working with independent testing laboratory Gaming Laboratories International(R) (“GLI”). According to the company, GLI provides world-class testing, certification and professional services to the global gaming industry's suppliers, regulators and operators across more than 480 jurisdictions. According to the announcement, the company successfully received certification for live dealer studio in accordance with GLI-19, Isle of Man and Ontario technical requirements, thereby better positioning the company for pending commercial agreements licensed in those jurisdictions. The company…

Continue Reading

ThursdayAug 11, 2022 11:50 am

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Shares Favre Interview

Odyssey Health (OTC: ODYY), formerly Odyssey Group International and a company focused on developing unique, life-saving medical products including a novel compound for the treatment of concussion, is sharing an interview by NFL Hall of Famer Brett Favre. During the interview, hosted by Bubba, the Love Sponge(R), Favre talks about the many concussions he received while playing football. Earlier this week, Favre did another interview with ODYY head of drug development Dr. Jacob VanLandingham, in which he also talked about concussions. During the interview with Bubba, the Love Sponge, Favre explained that when he left the NFL years ago, he…

Continue Reading

ThursdayAug 11, 2022 10:26 am

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) Announces Participation in Upcoming Q3 Investor Summit

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, will be presenting at the upcoming Q3 Investor Summit. The two-day event, which is slated for Aug. 16–17, 2022, is hosted by Investor Summit Group. GreenBox chair Ben Errez will be presenting virtually; his presentation is scheduled for Aug. 17, 2022, at 12:30 p.m. ET. In addition, Errez will host one-on-one meetings with investors during the summit. The Q3 Investor Summit is designed to connect companies with leading investors. To view the webcast, visit https://ibn.fm/ZR6NV To view the full press release, visit https://ibn.fm/dUfDJ About GreenBox POS GreenBox is an emerging financial technology…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered